Results 231 to 240 of about 179,384 (308)

Phenotyping of acute heart failure with preserved ejection fraction: real-world outcomes in a cohort of older patients. [PDF]

open access: yesIntern Med J
Burzo ML   +10 more
europepmc   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad   +9 more
wiley   +1 more source

Cardiac Magnetic Resonance Imaging in Heart Failure With Preserved Ejection Fraction. [PDF]

open access: yesCirc Cardiovasc Imaging
Kikuchi DS   +5 more
europepmc   +1 more source

Cardiac remodeling and arrhythmia in a mouse model of Depdc5 haploinsufficiency

open access: yesEpilepsia, EarlyView.
Abstract Objective Some ion channel genes linked to developmental and epileptic encephalopathy (DEE) are also linked to cardiac arrhythmia, leading to the hypothesis that predisposition to cardiac arrhythmias may contribute to the complex disease presentation of DEE and possibly to the mechanism of sudden unexpected death in epilepsy.
Roberto Ramos‐Mondragon   +9 more
wiley   +1 more source

Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction. [PDF]

open access: yesJAMA
Krüger N   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy